SCHEMBL28786033

SCHEMBL28786033

CO[C@H]1[C@@H](O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 16/20 1.00
ROCK2 O75116 10/20 1.00
PRKD3 O94806 8/20 1.00
PRKCG P05129 8/20 1.00
PRKCZ Q05513 8/20 1.00
PRKCB P05771 7/20 1.00
PRKCA P17252 7/20 1.00
PRKCH P24723 7/20 1.00
PRKCI P41743 7/20 1.00
PRKCE Q02156 7/20 1.00
PRKCD Q05655 7/20 1.00
PRKD1 Q15139 7/20 1.00
EGFR P00533 7/20 0.82
PRKACA P17612 7/20 0.82
PRKACG P22612 6/20 0.82
PRKACB P22694 6/20 0.82
CHEK1 O14757 3/20 0.79
MAPK1 P28482 3/20 0.79
KDR P35968 3/20 0.79
MEN1 O00255 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22765431 1.00 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL30207128 1.00 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL23259551 0.92 PRKCQ (0.84) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL20841734 0.91 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL22765238 0.91 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL12570343 0.91 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL12570346 0.91 PRKCQ (1.00) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL13169904 0.90 PRKCQ (0.82) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL10108144 0.89 PRKCQ (0.87) PRKCQROCK2PRKD3PRKCGPRKCZ
SCHEMBL2463656 0.89 PRKCQ (0.87) PRKCQROCK2PRKD3PRKCGPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101703509-A Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity NOVARTIS AG 2010-05-12 CN disclosed